mutations provided The truth that, as described beneath, CLL therapy is based over the presence or absence of such mutations. The current consensus is that, besides clonal mutations, subclonal mutations by using a variant allelic frequency ranging from 5 to 10% (and for that reason below the threshold of detection by typical molecular procedures) i